Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause

BACKGROUND: Outcomes and treatment effects of therapy may vary according to the cause of heart failure (HF). METHODS AND RESULTS: In this post hoc analysis of the EMPEROR‐Reduced (Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Reduced Ejection Fraction) trial, the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Shahzeb, Butler, Javed, Anker, Stefan D., Filippatos, Gerasimos, Ferreira, João Pedro, Pocock, Stuart J., Januzzi, James L., Piña, Ileana L., Böhm, Michael, Ponikowski, Piotr, Verma, Subodh, Brueckmann, Martina, Vedin, Ola, Zeller, Cordula, Zannad, Faiez, Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973606/
https://www.ncbi.nlm.nih.gov/pubmed/36565199
http://dx.doi.org/10.1161/JAHA.122.027652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973606/
https://www.ncbi.nlm.nih.gov/pubmed/36565199
http://dx.doi.org/10.1161/JAHA.122.027652

Ejemplares similares